Mira Pharmaceuticals (MIRA) Retained Earnings (2022 - 2025)

Mira Pharmaceuticals has reported Retained Earnings for 4 years, with the latest figure at -$39.6 million in Q4 2025.

• Quarterly Retained Earnings fell 226.31% year-over-year to -$39.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$39.6 million (down 226.31% YoY) and the FY2025 annual result came in at -$39.6 million, down 226.31% from the prior year.
• Retained Earnings fell to -$39.6 million in Q4 2025 per MIRA's latest filing, from -$33.6 million in the prior quarter.
• Over five years, Retained Earnings peaked at $33.0 million in Q2 2025 and troughed at -$39.6 million in Q4 2025.
• A 4-year average of -$4.7 million and a median of -$11.9 million in 2023 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 247.22% in 2024, then slumped 226.31% in 2025.
• Over 4 years, Retained Earnings stood at -$9.3 million in 2022, then tumbled by 128.8% to -$21.3 million in 2023, then jumped by 247.22% to $31.3 million in 2024, then plunged by 226.31% to -$39.6 million in 2025.
• According to Business Quant data, Retained Earnings over the past three periods registered -$39.6 million, -$33.6 million, and $33.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.